Organon & Co. (OGN)
Quarter-by-quarter results read from the company's own filed statements — period end, filing date, diluted EPS, revenue and year-over-year change. Consensus estimates are shown only where one exists.
Latest filed quarter
The most recent quarter Organon & Co. has filed, from EvidInvest's standardized statements.
Period end
Jun 30, 2026
Q2 FY2026
EPS (diluted)
$0.40
Est. $0.85 · -52.9%
Revenue
$1.56B
Est. $1.60B · -2.7%
Net income
$108.0M
As filed
EPS YoY
-28.6%
vs quarter ended 2025-06-30
Revenue YoY
-2.3%
vs quarter ended 2025-06-30
Next report
Nov 9, 2026
Third-party calendar date, not confirmed by a company filing · est. EPS $0.88
Run-rate
Trailing twelve months, summed from the last four filed quarters.
TTM EPS (diluted)
$0.78
2025-09-30 through 2026-06-30
TTM revenue
$6.13B
2025-09-30 through 2026-06-30
Filed quarters
26
On record here
EPS at or above estimate (4Q)
0%
Of the last four quarters that carry an estimate
Filed quarters
One row per filed statement, newest first
| Period end | Filed | EPS diluted | Revenue | EPS YoY | Revenue YoY | Est. EPS | Surprise |
|---|---|---|---|---|---|---|---|
| 2026-06-30Q2 FY2026 | 2026-07-31 | $0.40 | $1.56B | -28.6% | -2.3% | $0.85 | -52.9% |
| 2026-03-31Q1 FY2026 | 2026-05-04 | $0.55 | $1.46B | +66.7% | -3.5% | $0.83 | -33.7% |
| 2025-12-31Q4 FY2025 | 2026-02-24 | $-0.78 | $1.51B | -285.7% | -5.3% | $0.73 | -206.8% |
| 2025-09-30Q3 FY2025 | 2025-11-10 | $0.61 | $1.60B | -55.8% | +1.3% | $0.93 | -34.4% |
| 2025-06-30Q2 FY2025 | 2025-08-06 | $0.56 | $1.59B | -25.3% | -0.8% | $0.94 | -40.4% |
| 2025-03-31Q1 FY2025 | 2025-05-02 | $0.33 | $1.51B | -57.7% | -6.7% | $0.89 | -62.9% |
| 2024-12-31Q4 FY2024 | 2025-02-28 | $0.42 | $1.59B | -80.2% | -0.4% | $0.92 | -54.3% |
| 2024-09-30Q3 FY2024 | 2024-11-01 | $1.38 | $1.58B | +500.0% | +4.1% | $0.90 | +53.3% |
| 2024-06-30Q2 FY2024 | 2024-08-07 | $0.75 | $1.61B | -21.1% | -0.1% | $1.06 | -29.2% |
| 2024-03-31Q1 FY2024 | 2024-05-03 | $0.78 | $1.62B | +13.0% | +5.5% | $0.97 | -19.6% |
| 2023-12-31Q4 FY2023 | 2024-02-26 | $2.12 | $1.60B | +404.8% | +7.6% | $0.80 | +165.0% |
| 2023-09-30Q3 FY2023 | 2023-11-03 | $0.23 | $1.52B | -74.2% | -1.2% | $1.04 | -77.9% |
| 2023-06-30Q2 FY2023 | 2023-08-09 | $0.95 | $1.61B | +3.3% | +1.5% | $0.97 | -2.1% |
| 2023-03-31Q1 FY2023 | 2023-05-05 | $0.69 | $1.54B | -49.3% | -1.9% | $1.18 | -41.5% |
| 2022-12-31Q4 FY2022 | 2023-02-27 | $0.42 | $1.49B | -46.2% | -7.4% | $0.85 | -50.6% |
| 2022-09-30Q3 FY2022 | 2022-11-04 | $0.89 | $1.54B | -29.9% | -3.9% | $1.12 | -20.5% |
| 2022-06-30Q2 FY2022 | 2022-08-05 | $0.92 | $1.58B | -45.2% | -0.6% | $1.16 | -20.7% |
| 2022-03-31Q1 FY2022 | 2022-05-06 | $1.36 | $1.57B | -13.9% | +4.1% | $1.30 | +4.6% |
| 2021-12-31Q4 FY2021 | 2022-03-21 | $0.78 | $1.60B | -45.8% | -0.6% | $1.25 | -37.6% |
| 2021-09-30Q3 FY2021 | 2021-11-12 | $1.27 | $1.60B | -41.2% | -0.8% | — | — |
| 2021-06-30Q2 FY2021 | 2021-08-16 | $1.68 | $1.59B | -21.5% | +4.5% | — | — |
| 2021-03-31Q1 FY2021 | 2021-06-21 | $1.58 | $1.51B | -43.2% | -15.4% | — | — |
| 2020-12-31Q4 FY2020 | 2022-03-21 | $1.44 | $1.61B | — | — | — | — |
| 2020-09-30Q3 FY2020 | 2021-11-12 | $2.16 | $1.61B | — | — | — | — |
| 2020-06-30Q2 FY2020 | 2021-08-16 | $2.14 | $1.53B | — | — | — | — |
| 2020-03-31Q1 FY2020 | 2021-06-21 | $2.78 | $1.78B | — | — | — | — |